Mineralys Therapeutics, Inc. (MLYS) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q1'22 | Q4'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 6K | 0 | 15K | 0 | 0 | 0 | 0 | 0 | 8K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -6K | 0 | -15K | 0 | 0 | 0 | 0 | 0 | -8K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | 100% | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 45.34M | 38.28M | 41.12M | 46.75M | 44.45M | 51.77M | 60.11M | 45.17M | 35.35M | 27.71M | 26.27M | 15.73M | 14.94M | 10.01M | 7.42M | 7.57M | 7.08M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 20.98M | 13.88M | 9.68M | 8.47M | 6.57M | 7.2M | 6.12M | 5.89M | 4.6M | 4.03M | 3.77M | 3.85M | 2.65M | 2.19M | 1.36M | 791K | 467K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 24.36M | 24.4M | 31.45M | 38.28M | 37.88M | 44.57M | 53.98M | 39.27M | 30.75M | 23.68M | 22.5M | 11.88M | 12.29M | 7.82M | 6.06M | 6.78M | 6.62M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -45.34M | -38.28M | -41.13M | -46.75M | -44.45M | -51.77M | -60.11M | -45.17M | -35.36M | -27.71M | -26.27M | -15.73M | -14.94M | -10.01M | -7.42M | -7.57M | -7.08M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -2.01% | 26.05% | 31.57% | -3.49% | -25.69% | -86.81% | -128.77% | -187.05% | -136.73% | -176.89% | -253.94% | - | - | -41.3% | - | - | - |
| EBITDA | -45.33M | -38.27M | -41.12M | -46.73M | -44.43M | -51.75M | -60.09M | -45.16M | -35.35M | -27.67M | -26.27M | -15.73M | -14.94M | 0 | 0 | 0 | 0 |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -2.03% | 26.06% | 31.58% | -3.48% | -25.68% | -87.05% | -128.73% | -187% | -136.67% | - | - | - | - | - | - | - | - |
| D&A (Non-Cash Add-back) | 6K | 13K | 15K | 16K | 15K | 15K | 11K | 9K | 8K | 43.81K | 0 | 0 | 0 | 10.01M | 7.42M | 7.57M | 7.08M |
| EBIT | -45.34M | -38.28M | -36.93M | -46.75M | -44.45M | -51.77M | -60.11M | -45.17M | -35.36M | -27.71M | -26.27M | -15.73M | -14.94M | -10.01M | -7.42M | -7.57M | -7.08M |
| Net Interest Income | 6M | 6.04M | 4.2M | 3.47M | 2.24M | 2.81M | 3.77M | 4.15M | 3.85M | 3.32M | 3.51M | 3.59M | 2.33M | 935K | 741K | 0 | 0 |
| Interest Income | 6M | 6.04M | 4.2M | 3.47M | 2.24M | 2.81M | 3.77M | 4.15M | 3.85M | 3.32M | 3.51M | 3.59M | 2.33M | 935K | 741K | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 6M | 6.05M | 4.2M | 3.47M | 2.24M | 2.82M | 3.76M | 4.15M | 3.85M | 3.32M | 3.51M | 3.59M | 2.33M | 935K | 745K | 0 | 0 |
| Pretax Income | -39.34M | -32.23M | -36.93M | -43.27M | -42.21M | -48.95M | -56.34M | -41.01M | -31.51M | -24.39M | -22.76M | -12.14M | -12.61M | -9.07M | -6.68M | -7.57M | -7.08M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -39.34M | -32.23M | -36.93M | -43.27M | -42.21M | -48.95M | -56.34M | -41.01M | -31.51M | -24.39M | -22.76M | -12.14M | -12.61M | -9.07M | -6.68M | -7.57M | -7.08M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 6.8% | 34.14% | 34.45% | -5.51% | -33.97% | -100.69% | -147.55% | -237.81% | -149.9% | -168.81% | -240.82% | - | - | -28.1% | - | - | - |
| Net Income (Continuing) | -39.34M | -32.23M | -36.93M | -43.27M | -42.21M | -48.95M | -56.34M | -41.01M | -31.51M | -24.39M | -22.76M | -12.14M | -12.61M | -9.07M | -6.68M | -7.57M | -7.08M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.47 | -0.40 | -0.52 | -0.66 | -0.79 | -0.98 | -1.13 | -0.83 | -0.70 | -0.61 | -0.57 | -0.31 | -0.51 | -1.74 | -1.29 | -1.48 | -1.40 |
| EPS Growth % | 40.51% | 59.18% | 53.98% | 20.48% | -12.86% | -60.66% | -98.25% | -167.74% | -37.25% | 64.94% | 55.81% | - | - | -24.29% | - | - | - |
| EPS (Basic) | -0.47 | -0.40 | -0.52 | -0.66 | -0.79 | -0.98 | -1.13 | -0.83 | -0.70 | -0.61 | -0.57 | -0.31 | -0.51 | -1.74 | -1.29 | -1.48 | -1.40 |
| Diluted Shares Outstanding | 82.83M | 80.55M | 70.59M | 65.45M | 53.16M | 49.96M | 49.82M | 49.36M | 44.9M | 40.09M | 39.93M | 39.75M | 24.76M | 5.21M | 5.18M | 5.12M | 5.06M |
| Basic Shares Outstanding | 82.83M | 80.55M | 70.59M | 65.45M | 53.16M | 49.96M | 49.81M | 49.36M | 44.9M | 40.09M | 39.93M | 39.76M | 24.76M | 5.21M | 5.18M | 5.12M | 5.06M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |